Stem Cell Biotech: Seeking a Piece of the Action

Venture capital groups and big pharma have largely held back from investing in biotech companies focused on regenerative medicine. Will it take a clinical bullʹs eye to bring venture capitalists and big pharma into the cell therapy arena?